1-7 of 7
antidiarrheals
Close
Sort by
Journal Articles

Side Effects and Supportive Care in Relapsed or Refractory Classical Hodgkin Lymphoma Patients Treated in Later Lines of Therapy: A Pilot Analysis Conducted in 4 Countries

Clara Chen, PhD BS, MS, Katherine Byrne, Pam Hallworth, Christopher A. Yasenchak, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5653.
https://doi.org/10.1182/blood.V130.Suppl_1.5653.5653
Published: 2017
Journal Articles

Characterization of the Incidence and Management of Gastrointestinal Toxicity in the Phase 3 Panorama 1 Study of Panobinostat Plus Bortezomib and Dexamethasone Versus Placebo Plus Bortezomib and Dexamethasone in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma

Paul G. Richardson, Vania T M Hungria, MDPhD, Sung-Soo Yoon, MD PhD, Meral Beksac, MD, Meletios A. Dimopoulos, MD, Ashraf Elghandour, MD, Wieslaw Wiktor Jedrzejczak, MD, Andreas Guenther, MD, Thanyaphong Na Nakorn, MD PhD, Noppadol Siritanaratkul, MD, Robert L. Schlossman, MD, Jian Hou, MD PhD, Philippe Moreau, Sagar Lonial, MD, Jae Hoon Lee, MD PhD, Hermann Einsele, Hans Salwender, MD, Monika Sopala, Ashok Panneerselvam, Suman Redhu, Claudia Corrado, Florence Binlich, Jesus F. San Miguel
Journal: Blood
Blood (2014) 124 (21): 2120.
https://doi.org/10.1182/blood.V124.21.2120.2120
Published: 2014
Journal Articles

Bosutinib Safety Profile and Management of Toxicities in Leukemia Patients with Resistance or Intolerance to Imatinib and Other Tyrosine Kinase Inhibitors

Hagop M Kantarjian, Jorge E Cortes, Dong-Wook Kim, H. Jean Khoury, Tim H Brümmendorf, Kimmo Porkka, MD, PhD, Giovanni Martinelli, MD, Simon Durrant, Eric Leip, Nadine Besson, Virginia Kelly, Carlo Gambacorti-Passerini, MD
Journal: Blood
Blood (2011) 118 (21): 2760.
https://doi.org/10.1182/blood.V118.21.2760.2760
Published: 2011
Journal Articles

Safety and Management of Toxicities in the BELA Trial of Bosutinib Versus Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Carlo Gambacorti-Passerini, MD, Jorge E Cortes, Patricia Harris, Christine Powell, Athena Countouriotis, Hagop M Kantarjian
Journal: Blood
Blood (2011) 118 (21): 1685.
https://doi.org/10.1182/blood.V118.21.1685.1685
Published: 2011
Journal Articles

Phase I Study of S-trans, Trans-farnesylthiosalicylic Acid (FTS), a Novel Oral Ras Inhibitor, in Patients with Refractory Hematologic Malignancies.

Gautam Borthakur, MD, Farhad Ravandi, MD, Susan O’Brien, MD, Miloslav Beran, MD, Betsy Williams, RN, Howard Goldsweig, MD, Francis Giles, MD
Journal: Blood
Blood (2007) 110 (11): 1600.
https://doi.org/10.1182/blood.V110.11.1600.1600
Published: 2007
Journal Articles

Final Results of a Dose Escalation Study of Flavopiridol in Acute Leukemias Using a Novel Treatment Schedule.

William Blum, MD, Rebecca B. Klisovic, MD, Amy Johnson, PhD, Cheryl Kefauver, RN, Mitch Phelps, PhD, David Lucas, PhD, Lenguyen Huynh, Shujun Liu, PhD, James T. Dalton, PhD, Michael R. Grever, MD, Guido Marcucci, MD, John C. Byrd, MD
Journal: Blood
Blood (2007) 110 (11): 890.
https://doi.org/10.1182/blood.V110.11.890.890
Published: 2007
Journal Articles

Autologous Hematopoietic Stem Cell Transplantation for Crohn’s Diseases - 5 Cases Report.

Jian Ouyang, MD, Longdian Chen, MD, Bing Chen, MD, Jingyan Xu, Cuiping Li, De Pei Wu, MD
Journal: Blood
Blood (2006) 108 (11): 5437.
https://doi.org/10.1182/blood.V108.11.5437.5437
Published: 2006